comparemela.com
Home
Live Updates
PharmaEssentia Enters Into Exclusive Global License Agreement With WuXi Biologics for a Myeloid Immune Checkpoint Antibody Candidate : comparemela.com
PharmaEssentia Enters Into Exclusive Global License Agreement With WuXi Biologics for a Myeloid Immune Checkpoint Antibody Candidate
The potential development program reflects PharmaEssentia’s efforts to diversify its current expertise and expand its pipeline with a new solid tumor mechanism
...
Related Keywords
Ling Lin ,
Tainan Municipality ,
Taiwan ,
China ,
Japan ,
Taipei ,
T Ai Pei ,
United States ,
American ,
Taiwanese ,
Ko Chung Lin ,
Pharmaessentia Tpex ,
Pharmaessentia Corporation ,
Wuxi Biologics Ireland ,
Wuxi Biologics Ireland Limited ,
Chief Executive Officer ,
Wuxi Biologics ,
Lih Ling Lin ,
Chief Scientific Officer ,
Private Securities Litigation Reform Act ,
Markets ,
comparemela.com © 2020. All Rights Reserved.